Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by University Hospital Muenster.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT01361334
First received: May 17, 2011
Last updated: May 25, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)